160 related articles for article (PubMed ID: 16322684)
21. G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.
Ahn JI; Yoo JY; Kim TH; Kim YI; Broaddus RR; Ahn JY; Lim JM; Jeong JW
BMC Cancer; 2019 Aug; 19(1):810. PubMed ID: 31412816
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
23. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
24. Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.
Park DW; Ryu HS; Choi DS; Park YH; Chang KH; Min CK
Gynecol Oncol; 2001 Sep; 82(3):442-9. PubMed ID: 11520138
[TBL] [Abstract][Full Text] [Related]
25. Genetic targeting of relaxin and insl3 signaling in mice.
Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
[TBL] [Abstract][Full Text] [Related]
26. Effects of BMI1 Gene on Regulating Apoptosis, Invasion, and Migration of HEC-1B Cells Induced by Ionizing Radiation.
Chen L; Luo W; Ji P; Li Z; Yan Y; Zhou Q
J Healthc Eng; 2022; 2022():7052066. PubMed ID: 35281533
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
[TBL] [Abstract][Full Text] [Related]
28. Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates.
Ivell R; Balvers M; Pohnke Y; Telgmann R; Bartsch O; Milde-Langosch K; Bamberger AM; Einspanier A
Reprod Biol Endocrinol; 2003 Nov; 1():114. PubMed ID: 14633277
[TBL] [Abstract][Full Text] [Related]
29. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
30. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.
Monge M; Colas E; Doll A; Gonzalez M; Gil-Moreno A; Planaguma J; Quiles M; Arbos MA; Garcia A; Castellvi J; Llaurado M; Rigau M; Alazzouzi H; Xercavins J; Alameda F; Reventos J; Abal M
Cancer Res; 2007 Jul; 67(14):6753-9. PubMed ID: 17638886
[TBL] [Abstract][Full Text] [Related]
31. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
32. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
33. The association of transforming growth factor-beta 1 with myometrial invasion of endometrial carcinomas through effects on matrix metalloproteinase.
Yabushita H; Narumiya H; Hiratake K; Yamada H; Shimazu M; Sawaguchi K; Noguchi M; Nakanishi M
J Obstet Gynaecol Res; 2000 Jun; 26(3):163-70. PubMed ID: 10932976
[TBL] [Abstract][Full Text] [Related]
34. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
Guo W; Chen G; Zhu C; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
[TBL] [Abstract][Full Text] [Related]
36. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
38. Relaxin regulates endometrial structure and function in the rhesus monkey.
Goldsmith LT; Weiss G
Ann N Y Acad Sci; 2005 May; 1041():110-7. PubMed ID: 15956693
[TBL] [Abstract][Full Text] [Related]
39. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y; Hiramatsu K; Funauchi M; Shiomi M; Masuda T; Kakuda M; Nakagawa S; Miyoshi A; Matsuzaki S; Kobayashi E; Kimura T; Serada S; Ueda Y; Naka T; Kimura T
BMC Cancer; 2022 Jun; 22(1):679. PubMed ID: 35729527
[TBL] [Abstract][Full Text] [Related]
40. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Karahan N; Güney M; Baspinar S; Oral B; Kapucuoglu N; Mungan T
Eur J Gynaecol Oncol; 2007; 28(3):184-8. PubMed ID: 17624083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
